Target intelligence / Profile preview

Defensin beta 131D pseudogene (DEFB131D)

Target: DEFB131D
Molecular classification: Other (pseudogene)

Overview

Defensin beta 131D (DEFB131D) is annotated as a pseudogene, indicating it does not encode a functional protein or peptide in humans. It belongs to the same genomic region as other beta-defensin genes, which are small, cysteine-rich, cationic peptides with well-established roles in innate immunity and antimicrobial defense. However, as a pseudogene, DEFB131D lacks functional transcripts or protein products, and there is no evidence that it serves as a therapeutic target or that it plays any direct biological or disease role. Similar names like DEFB131A or DEFB131B represent actual protein-coding genes, in contrast to DEFB131D.

Other names: Defensin beta 131DDEFB131Ddefensin beta 131 pseudogene

Beyond the preview

Go deeper on Defensin beta 131D pseudogene (DEFB131D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Defensin beta 131D pseudogene (DEFB131D).

Explore the full profile